Fair Money & Economic Opportunity

NeuroSense Therapeutics Ltd. is a clinical-stage biotechnology company focused on developing treatments for neurodegenerative diseases. The provided articles detail its clinical trials, financial results, and regulatory milestones. There is no evidence that the company operates as a financial institution or offers any lending, deposit, or other financial services to consumers.

Therefore, all KPIs related to 'Fair Money & Economic Opportunity' are not applicable to this company, aligning with the '0' tier in the rubric for non-financial entities or those not offering relevant products/services.

Honest & Fair Business

The company filed reissued audited financial statements for all periods covered by its 2023 financial statements with the Securities and Exchange Commission on Form 6-K on February 11, 2026.

This indicates one financial restatement within the past three years.

Kind to Animals

The company uses animals for drug testing, specifically employing Zebrafish as pre-clinical animal models.

There is no explicit mention of an animal testing policy in the provided documents, nor is there evidence of non-animal testing methods being employed.

Planet-Friendly Business

No specific sustainability data or planet-friendly business metrics are available for NeuroSense Therapeutics Ltd. (NRSN.US) in the provided articles.

Information regarding environmental impact, emissions, targets, or initiatives is not disclosed for the company.

Safe & Smart Tech

NeuroSense Therapeutics stated in August 2024 that there have been no material breaches, violations, or unauthorized uses of its IT systems or data that required notification, nor any incidents under internal review or investigation.

The company represents that it has implemented and maintained commercially reasonable physical, technical, and administrative controls and safeguards to protect its confidential and personal data. Users can request deletion or modification of their personal information by emailing the company. The company collects both non-personal and personal information, including IP addresses, and uses cookies. Its privacy policy, last revised May 22, 2022, states that data is retained for as long as necessary to fulfill the purposes for which it was collected, including legal, accounting, or reporting requirements. The company represents that it is in material compliance with applicable data privacy laws and regulations, including HIPAA, CCPA, and GDPR, and has policies and procedures in place for data privacy and security. It also states that it has not received notice of any actual or potential liability or violation under these privacy laws.